Page 12 - Embecta Corp News Today

Dividend investing came into limelight in 2022 after the stock market began to fall amid rising inflation, interest rate hikes, and an uncertain global geopolitical situation worsened by the Russian invasion...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are...

NEW YORK, Jan. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Embecta Corp. (“Embecta” or the “Company”)...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are...

20.12.2022 - PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) - Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for the three and twelve month periods ended ...

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 50 points on Tuesday. Following the market opening Tuesday, the ...

PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P....

This week's patents include a stroller attachment, battery cells and e-cigarette. (BizSense Pro subscription required)